COVID-19 Implications for Pharmaceutical Litigation

In this podcast, Ceren Canal Aruoba, Principal, Cornerstone Research, speaks to Darius Lakdawalla, Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, University of Southern California, about the economics of pharmaceutical markets. The podcast discusses the impacts of COVID-19 from the manufacturer perspective including innovation and vaccine liability issues and explores how the manufacturers might interact with the other stakeholders in the pharmaceutical markets to address issues raised by COVID-19. In addition, Professor Lakdawalla talks about the use of economic analysis in pharmaceutical litigation and the challenges brought on by COVID-19 in this process. Sponsored by Cornerstone Research